Legal Representation
Attorney
EDWARD KELLY
USPTO Deadlines
Next Deadline
2097 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2001-04-10)
Due Date
April 10, 2031
Grace Period Ends
October 10, 2031
Application History
25 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 5, 2021 | CAEX | O | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
| Mar 21, 2011 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| Mar 21, 2011 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| Mar 7, 2011 | I | PAPER RECEIVED | |
| Mar 7, 2011 | 89AF | I | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
| Dec 3, 2008 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED |
| May 12, 2007 | PLGL | A | ASSIGNED TO PARALEGAL |
| May 12, 2007 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Apr 10, 2007 | I | PAPER RECEIVED | |
| Apr 10, 2007 | 815F | I | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED |
| Nov 14, 2006 | CFIT | O | CASE FILE IN TICRS |
| Nov 1, 2003 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Apr 10, 2001 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Nov 28, 2000 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Oct 25, 2000 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 24, 2000 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Aug 25, 2000 | IUAF | S | USE AMENDMENT FILED |
| Apr 11, 2000 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 18, 2000 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 17, 1999 | NPUB | O | NOTICE OF PUBLICATION |
| Aug 26, 1999 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 26, 1999 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 1, 1999 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 12, 1999 | CNRT | F | NON-FINAL ACTION MAILED |
| Jan 28, 1999 | DOCK | D | ASSIGNED TO EXAMINER |
Additional Information
Translation
THE ENGLISH TRANSLATION OF BIOLOGISCHE ARZNEMITTEL IS BIOLOGICAL DRUGS
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOLOGISCHE ARZNEIMITTEL"
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO